Drug Profile
PPM 202
Alternative Names: PPM-202Latest Information Update: 05 Oct 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 14 Mar 2007 Phase-I clinical trials in Type-2 diabetes mellitus in USA (PO)